Obesity 28(6):10501061 Kusminski CM, Perez-Tilve D, Mller TD, DiMarchi RD, Tschp MH, Scherer PE (2024) Transforming obesity: The advancement of multi-receptor drugs
APAC Anti-obesity Drugs Market Asia-Pacific is forecast to post a 35.21% CAGR through 2031, the fastest among all regions, aided by regulatory approvals in China, Japan, and India alongside rapid middle-class expansion
Loffredo, L., Marcoccia, A., Pignatelli, P., Andreozzi, P., Borgia, M
As the conversation around weight shifts toward long-term health, our commitment to delivering the most trusted, science-backed, and holistic solutions grounded in community support and lasting results has never been stronger, or more important, said Tara Comonte, Chief Executive Officer of WW